Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KRAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HDAC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCTN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PFN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANO10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR7E37P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NDRG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST3GAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTSB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM171A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMPRSS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPHB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETDB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C9orf66 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPST2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYRM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MNX1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on